CD200 depletion in glioma enhances antitumor immunity and induces tumor rejection
Itay Raphael, Anzar Mujeeb, Elisabet Ampudia-Mesias, ReidAnn E. Sever, Brandon L. McClellan, Stephen C. Frederico, Chaim T. Sneiderman, Apoorva Mirji, A. S. Daba, Francisco Puerta-Martinez, Michal Nisnboym, Wilson Barry Edwards, Michael W. Graner, Christopher L. Moertel, Maria Graciela Castro, , Michael R. Olin
This study shows that CD200 depletion in gliomas enhances antitumor immunity and leads to tumor rejection by modulating immune cell activity and cytokine expression.
bioRxiv · Sep 8, 2024 · PreprintImmunology